SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) price, chart and market data
SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) has its Arbitrum contract at 0xf1d092ac2f5861b3588673e9f6a2d09b081a76fd. The contract check raised a critical flag: this creator has deployed a honeypot before. About 2 addresses hold it on Arbitrum. The wallets among its ten largest holders hold 100.0% of RXBI (pools, bridges and burn addresses left out). Of the 374 Tokenized Exchange-Traded Funds (ETFs) coins whose contracts Heriux has read, 7 can mint new supply and 6 can freeze balances; SPDR S&P Biotech ETF Tokenized Stock (Reality)'s contract can do neither.
Other Tokenized Exchange-Traded Funds (ETFs) coins
- Market Cap
- $6.03K
- 24h Volume
- $0.00
- 24h High
- —
- 24h Low
- —
- FDV
- $6.03K
- Circulating Supply
- 40 RXBI
- Total Supply
- 40 RXBI
- Max Supply
- ∞
Updated Nov 4, 2026, 2:10 AM · via DexScreener
RXBI today · 7.5% below its peak.
RXBI todaysnapshot at 17:08 UTC
As of Oct 23, 16:47 UTC: SPDR S&P Biotech ETF Tokenized Stock (Reality) last traded at $150.03; there is no 24-hour change to compare against.
Generated from platform data · Nov 4, 2026, 5:08 PM · Not investment advice
Heriux Insights
Readings computed from RXBI's own price history. Each links to its method.
Recovery Pressure
How far the price is from its peak, and what it takes to get back.Heriux OriginalDown 7.5% from its peak of $162.22 (Sep 22, 2026). To get back it needs +8.1%.
Peak = all-time high reported by the data provider (intraday).
Unlock Burden
Supply that exists but is not yet circulating.Heriux Original0.0% of the total supply is not yet in circulation.
Each reading describes RXBI's past price, not where it goes next, and none is a buy or sell signal. Supply figures come from the data provider and can be incomplete. How each is computed.
SPDR S&P Biotech ETF Tokenized Stock (Reality) Contract Security
What the token's own smart contract permits, read directly from the chain.
The contract holds a power that can be used to take or block holder funds. 1 issuer control listed below is standard for this asset class and is not counted as a defect.
Findings
Issuer controls
Standard for this asset class and excluded from the verdict above — but real powers a holder should know the issuer has.
- Chain
- arbitrum-one
- Source code
- Verified
- Holders
- 2
- Buy / sell tax
- 0% / 0%
- Contract
- 0xf1d092…1a76fd
Checked Nov 1, 2026. A contract scan describes code permissions only. It cannot tell you whether a team will deliver, whether reserves exist, or whether a token holds its value.
About SPDR S&P Biotech ETF Tokenized Stock (Reality)
What is SPDR S&P Biotech ETF Tokenized Stock (Reality)?
SPDR S&P Biotech ETF Tokenized Stock (Reality) project details
RXBI market position
RXBI price history
Volatility Indicator
–Insufficient DataNot enough price history yet — 0 of 10 days needed before a volatility reading means anything.
Not enough price history yet — 0 of 10 days needed before a volatility reading means anything. History is collected automatically as prices are ingested.
Frequently Asked Questions
Is SPDR S&P Biotech ETF Tokenized Stock (Reality) safe to buy?
Is SPDR S&P Biotech ETF Tokenized Stock (Reality) a honeypot?
What is the current price of SPDR S&P Biotech ETF Tokenized Stock (Reality)?
What is SPDR S&P Biotech ETF Tokenized Stock (Reality)'s market capitalisation?
How has RXBI performed historically?
How many RXBI are in circulation?
Which network does RXBI run on?
What is the RXBI contract address?
Can new RXBI be minted, or balances frozen?
How many holders does RXBI have?
Do a few wallets hold most of RXBI?
How does RXBI's contract compare with other Tokenized Exchange-Traded Funds (ETFs) coins?
How we price SPDR S&P Biotech ETF Tokenized Stock (Reality)
The source of the spdr s&p biotech etf tokenized stock (reality) price shown is not recorded. The deepest on-chain pool for this token, read from DexScreener every four hours and again when the page is opened.
All prices are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results.